Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Curetis secures up to €20mm in convertible debt financing

Executive Summary

Curetis NV (molecular diagnostics for infectious diseases) secured up to €20mm ($23.2mm) in convertible debt financing with Yorkville Advisors. Curetis drew down the initial €3.5mm (net €3.22mm of the €5mm first tranche. The company will use the proceeds for commercial expansion and R&D activities.
Deal Industry
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
Deal Status
  • Final
Deal Type
  • Financing
    • Convertible Debt
    • Private Placement

Related Companies